{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:49:31Z","timestamp":1790135371531,"version":"4.0.1"},"reference-count":65,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>The purpose of the study is to assess the health of patients in the activity of tertiary prevention dedicated to preventing blindness caused by POAG (primary glaucoma with open angle and high tension) and NTG (primary glaucoma with open-angle and statistically normal tension\u2014particular form of glaucoma with open angle) and preservation of the remaining visual function. The design of the study is epidemiological, observational, descriptive and retrospective, and uses only the data recorded in the existing records in the archives of the Ophthalmology office within the Integrated Outpatient Clinic of the Emergency Clinical Hospital of Oradea (IOCECHO) during the years 1999\u20132019 (anamnestic data; objective examination and paraclinical examination: intraocular pressure\u2014IOP and visual field\u2014VF). The methods of the study included the standardized protocol: anamnesis, physical ophthalmological examination, IOP determination, and computerized perimetry with the \u201cFast Threshold\u201d strategy performed with the \u201cOpto AP-300\u201d perimeter. The obtained results were statistically processed with a specialized software (S.P.S.S.\u2014I.B.M. Statistics version 22). The study examined the available data of 522 patients of which 140 were men (26.8%) and 382 were women (73.2%). The gender ratio was 0.37. In the period 1999\u20132019, 150,844 people with ophthalmic pathology were consulted in the Ophthalmology office of IOCECHO out of which 522 patients (0.35%) were diagnosed with primitive open-angle glaucoma, 184 people (35.2%) presented high IOP (POAG), and 338 people (64.8%) had statistically normal IOP (NTG). The annual proportion of cases diagnosed with glaucoma in the total number of patients examined was between 0.1% (2005; 2008; 2010) and 2.4% in 2012, when 101 people were detected. In the studied records, no cases of uni- and\/or bilateral blindness were mentioned. The mean age of glaucoma patients at the first consultation was 60.81 \u00b1 12.14 years with high frequencies in the 55\u201369 age groups and at the last consultation it was 66.10 \u00b1 12.47 years with high frequencies in the age groups between 60\u201374 years. Monitoring and treatment of glaucoma patients was beneficial; IOP decreased statistically significantly: in patients with POAG by 46.16%, from 30.50 \u00b1 7.98 mmHg to 16.42 \u00b1 3.01 mmHg (p = 0.000) and in those with NTG by 17.44%, at 16.39 \u00b1 3.66 mmHg at 13.53 \u00b1 1.92 mmHG (p = 0.000). The duration of treatment and monitoring was on average 5.1 \u00b1 3.4 years, for 184 patients (35.2%) with POAG and 5.1 \u00b1 3.8 years for 338 patients (64.8%) with NTG. Tertiary prevention of glaucoma, by providing specialized care, ensures effective control of IOP and implicitly of the long-term evolution of the disease. IOP is the only modifiable risk factor in patients with POAG and NTG and its decrease prevents the progression of the disease and emphasizes the importance of early diagnosis and treatment. The management of the glaucoma patient consisted of: complete ophthalmological examination (subjective and objective), paraclinical examination with IOP, and VF measurement (valuable ophthalmological diagnostic tool) for disease detection and effective assessment of disease progression in order to improve the process of therapeutic decision making.<\/jats:p>","DOI":"10.3390\/jpm11090830","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T22:12:22Z","timestamp":1629843142000},"page":"830","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Aspects of Tertiary Prevention in Patients with Primary Open Angle Glaucoma"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-8030","authenticated-orcid":false,"given":"Gabriel Zeno","family":"Munteanu","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno Virgiliu Ioan","family":"Munteanu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Roiu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian Marius","family":"Daina","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Moraru","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviu","family":"Moraru","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Trambitas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-3531","authenticated-orcid":false,"given":"Dana","family":"Badau","sequence":"additional","affiliation":[{"name":"Petru Maior Faculty of Sciences and Letters, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania"},{"name":"Faculty of Physical Education and Mountain Sports, Interdisciplinary Doctoral School, Transilvania University, 500068 Brasov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Georgeta","family":"Daina","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.pop.2015.05.008","article-title":"Glaucoma","volume":"42","author":"Mantravadi","year":"2015","journal-title":"Prim. Care"},{"key":"ref_2","unstructured":"(2021, March 29). Despre Glaucom, Societatea de Glaucom. Available online: https:\/\/societateadeglaucom.ro\/glaucom\/."},{"key":"ref_3","first-page":"887","article-title":"Glaucoma is second leading cause of blindness globally","volume":"82","author":"Kingman","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/aos.12933","article-title":"Glaucoma blindness at the end of life","volume":"95","author":"Mokhles","year":"2017","journal-title":"Acta. Ophthalmol."},{"key":"ref_6","unstructured":"(2021, March 22). Guidelines\u2014European Glaucoma Society. Available online: https:\/\/www.eugs.org\/eng\/guidelines.asp."},{"key":"ref_7","unstructured":"Chis\u0103li\u021b\u0103, D. (2020). Glaucomul Primitiv cu Unghi Deschis, G\u00e2nduri \u0219i Sinteze Practice, Publishing House Cermi. [2nd ed.]."},{"key":"ref_8","first-page":"e11686","article-title":"Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"ref_9","unstructured":"(2021, April 11). Terminology and Guidelines for Glaucoma, Available online: http:\/\/www.icoph.org\/dynamic\/attachments\/resources\/egs_guidelines_4_english.pdf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2017.0041","article-title":"Targets of Neuroprotection in Glaucoma","volume":"34","author":"He","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_11","unstructured":"Boc\u015fan, I.S., Boc\u015fan, I.S., R\u0103dulescu, A., Brumboiu, I., \u015euteu, O., and Achima\u015f, A. (1999). Epidemiologie Practic\u0103 Pentru Medicii de Familie, Publishing House Medical\u0103 Universitar\u0103: Iuliu Ha\u0163ieganu."},{"key":"ref_12","unstructured":"Enachescu, D., and Marcu, M.G. (1995). Public Health and Sanitary Management, Publishing House ALL."},{"key":"ref_13","unstructured":"Vl\u0103descu, C. (2004). Public Health and Medical Menagement, Publishing House Cartea Universitara."},{"key":"ref_14","unstructured":"Boc\u0219an, I., R\u0103dulescu, I., and R\u0103dulescu, A. (2002). Cuno\u015ftin\u0163e Fundamentale Pentru Manageri \u00een S\u0103n\u0103tate Public\u0103, Vol. I, II, Publishing House Alma Mater."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuron.2012.10.002","article-title":"The neuronal organization of the retina","volume":"76","author":"Masland","year":"2012","journal-title":"Neuron"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/OPTH.S3361","article-title":"Hypoxia-ischemia and retinal ganglion cell damage","volume":"2","author":"Kaur","year":"2008","journal-title":"Clin. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0028-1124020","article-title":"The optic nerve","volume":"29","author":"Selhorst","year":"2009","journal-title":"Semin. Neurol."},{"key":"ref_19","unstructured":"Tasman, W.S., and Jaeger, E.A. (2006). Ocular anatomy, embryology, and teratology\u2014Chapter 2: Prenatal development of the eye and its adnexa. Duane\u2019s Ophthalmology, Lippincott Williams and Wilkins, VO."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5935\/0004-2749.20160077","article-title":"Normal-tension glaucoma: An update","volume":"79","author":"Esporcatte","year":"2016","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_22","unstructured":"(2020, February 24). Opto Global, Manual de Utilizare a Perimetrului Computerizat Opto AP-300. Available online: https:\/\/www.freymedical.eu\/products\/visual-field-analyzer\/ap-300\/."},{"key":"ref_23","unstructured":"B\u0103icu\u0219, C. (2007). Medicina Bazat\u0103 pe Dovezi: Cum \u00cen\u021belegem Studiile, Publishing House Medical\u0103."},{"key":"ref_24","unstructured":"Jaba, E., and Grama, A. (2004). Analiza Statistic\u0103 cu SPSS Sub Windows, Publishing House Polirom."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.APO.0000605096.48529.9c","article-title":"Latest Developments in Normal-Pressure Glaucoma: Diagnosis, Epidemiology, Genetics, Etiology, Causes and Mechanisms to Management","volume":"8","author":"Lee","year":"2019","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5999\/aps.2018.00010","article-title":"Trends in statistical methods in articles published in Archives of Plastic Surgery between 2012 and 2017","volume":"45","author":"Han","year":"2018","journal-title":"Arch. Plast. Surg."},{"key":"ref_27","first-page":"249","article-title":"Clinical analysis of glaucoma in hospital patients","volume":"3","author":"Rijal","year":"2005","journal-title":"Kathmandu Univ. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jfo.2011.10.008","article-title":"Hypertonie oculaire et glaucome primitif \u00e0 angle ouvert [High intraocular pressure and open angle glaucoma]","volume":"35","author":"Agbahoungba","year":"2012","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_29","first-page":"484","article-title":"Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0000000000000227","article-title":"Screening for Primary Open-angle Glaucoma (POAG)","volume":"58","author":"DeVience","year":"2018","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Song, Y.J., Kim, Y.W., Park, K.H., Kim, Y.K., Choi, H.J., and Jeoung, J.W. (2019). Comparison of glaucoma patients referred by glaucoma screening versus referral from primary eye clinic. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210582"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ophtha.2006.08.051","article-title":"Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4103\/ijo.IJO_2310_19","article-title":"Commentary: Assessment of glaucoma referral letter for quality and accuracy among patients referred to a tertiary eye care centre","volume":"68","author":"Kaushik","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-2005-858734","article-title":"Diagnostische M\u00f6glichkeiten zur Fr\u00fcherkennung der Glaukomprogression [Diagnostic approaches for early detection of glaucoma progression]","volume":"223","author":"Arend","year":"2006","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs: A meta-analysis of randomized clinical trials","volume":"112","author":"Webers","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.NAJ.0000345434.37734.ee","article-title":"Primary open-angle glaucoma","volume":"109","year":"2009","journal-title":"Am. J. Nurs."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"He, J., Zou, H., Lee, R.K., Tong, X., Tang, W., Zhang, Y., Zhao, R., and Ge, L. (2015). Prevalence and risk factors of primary open-angle glaucoma in a city of Eastern China: A population-based study in Pudong New District, Shanghai. BMC Ophthalmol., 15.","DOI":"10.1186\/s12886-015-0124-x"},{"key":"ref_39","first-page":"1937","article-title":"Open-angle glaucoma","volume":"67","author":"Distelhorst","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00417-014-2767-3","article-title":"Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: Results of an 18-year follow-up","volume":"252","author":"Komori","year":"2014","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.10.001","article-title":"Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma","volume":"56","author":"Liebmann","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICU.0000000000000461","article-title":"Recent developments in visual field testing for glaucoma","volume":"29","author":"Wu","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.survophthal.2016.03.006","article-title":"Management of advanced glaucoma: Characterization and monitoring","volume":"61","author":"Liebmann","year":"2016","journal-title":"Surv. Ophthalmol."},{"key":"ref_44","first-page":"57","article-title":"How do you interpret a 24-2 Humphrey Visual Field printout","volume":"1","author":"Kahook","year":"2007","journal-title":"Glaucoma Today"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cxo.12551","article-title":"The value of visual field testing in the era of advanced imaging: Clinical and psychophysical perspectives","volume":"100","author":"Phu","year":"2017","journal-title":"Clin. Exp. Optom."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jcjo.2014.10.002","article-title":"Selecting visual field tests and assessing visual field deterioration in glaucoma","volume":"49","year":"2014","journal-title":"Can. J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/08820530009037869","article-title":"Current practice with standard automated perimetry","volume":"15","author":"Bosworth","year":"2000","journal-title":"Semin. Ophthalmol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00055735-199504000-00007","article-title":"Pattern of visual field defects in normal-tension and high-tension glaucoma","volume":"6","author":"Araie","year":"1995","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_49","first-page":"274","article-title":"Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes","volume":"39","author":"Koseki","year":"1995","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"205-vi","DOI":"10.1016\/S0896-1549(03)00005-1","article-title":"Standard perimetry","volume":"16","author":"Anderson","year":"2003","journal-title":"Ophthalmol Clin. N. Am."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1097\/OPX.0b013e3182004c3b","article-title":"A history of perimetry and visual field testing","volume":"88","author":"Johnson","year":"2011","journal-title":"Optom Vis. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ophtha.2017.04.009","article-title":"Will Perimetry Be Performed to Monitor Glaucoma in 2025?","volume":"124","author":"Camp","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.revmed.2018.12.001","article-title":"Le glaucome primitif \u00e0 angle ouvert [Primary open-angle glaucoma]","volume":"40","author":"Bertaud","year":"2019","journal-title":"Rev. Med. Interne."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/eye.2010.112","article-title":"Focusing on glaucoma progression and the clinical importance of progression rate measurement: A review","volume":"24","author":"Rossetti","year":"2010","journal-title":"Eye"},{"key":"ref_55","first-page":"30256","article-title":"Transscleral Cyclophotocoagulation for Glaucoma in the Setting of Uveal Melanoma","volume":"20","author":"Shukla","year":"2020","journal-title":"Ophthalmol Glaucoma."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1755-3768.2011.02328.x","article-title":"The times they are a-changin\u2019: Time to change glaucoma management","volume":"91","author":"Heijl","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/02713683.2016.1184281","article-title":"Value of Structural and Hemodynamic Parameters for the Early Detection of Primary Open-Angle Glaucoma","volume":"42","author":"Kurysheva","year":"2017","journal-title":"Curr. Eye Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/ijo.IJO_875_16","article-title":"Prognosis of different glaucomas seen at a tertiary center: A 10-year overview","volume":"65","author":"Sihota","year":"2017","journal-title":"Indian J. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/0301-4738.100546","article-title":"Glaucoma in developing countries","volume":"60","author":"Thomas","year":"2012","journal-title":"Indian J. Ophthalmol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.icu.0000193088.75432.c9","article-title":"Glaucoma screening: Current trends, economic issues, technology, and challenges","volume":"17","author":"Nduaguba","year":"2006","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_61","first-page":"263","article-title":"Anatomical variations of the obturator veins and their surgical implications","volume":"38","author":"Szabo","year":"2017","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_62","first-page":"189","article-title":"Coronary Sinus Lactate as Marker of Myocardial Ischemia in Cardiac Surgery: Correlation with Morbidity and Mortality after Cardiac Surgery","volume":"23","author":"Raicea","year":"2015","journal-title":"Rev. Romana Med. Lab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in Adults-Screening, Diagnosis, and Management: A Review","volume":"325","author":"Stein","year":"2021","journal-title":"JAMA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5301\/EJO.2010.6112","article-title":"Do adherence rates and glaucomatous visual field progression correlate?","volume":"21","author":"Rossi","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_65","first-page":"20","article-title":"Research on intraoperative iris behavior in rabbits treated with tamsulosin and finasteride","volume":"19","author":"Horvath","year":"2015","journal-title":"Hippokratia"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/9\/830\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:50:37Z","timestamp":1760165437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/9\/830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["jpm11090830"],"URL":"https:\/\/doi.org\/10.3390\/jpm11090830","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}